|1.||Postma, Dirkje S: 5 articles (12/2012 - 01/2005)|
|2.||Scheper, Rik J: 5 articles (03/2009 - 11/2003)|
|3.||Timens, Wim: 4 articles (12/2012 - 01/2005)|
|4.||Mahjoubi, Frouzandeh: 3 articles (01/2013 - 05/2008)|
|5.||Bates, Susan E: 3 articles (09/2011 - 02/2002)|
|6.||Haber, Michelle: 3 articles (08/2009 - 10/2005)|
|7.||Scheffer, George L: 3 articles (03/2009 - 11/2003)|
|8.||van der Deen, Margaretha: 3 articles (01/2008 - 01/2005)|
|9.||Baer, Maria R: 2 articles (04/2015 - 03/2005)|
|10.||Chen, Siying: 2 articles (10/2014 - 06/2014)|
|1.||Breast Neoplasms (Breast Cancer)
01/01/2014 - "Multidrug resistance-associated protein 1 coded by the ABCC1 gene has recently been suggested as a potential prognostic marker in breast cancer patients. "
11/01/2010 - "We found that the resistance was not associated with multidrug resistance transporter 1 (p170, p-gp), multidrug resistance-associated protein 1 and breast cancer resistance protein overexpression, so we hypothesized that Tca8113/PYM cells must have some other resistance mechanism selected by PYM. "
07/01/2010 - "Mucosal explants exhibited nanoparticle penetration and internalization in the spinous and basal epithelial layers (7/10 specimens), and also exhibited the presence of the phase-III efflux transporters multidrug resistance-associated protein 1 (MRP1) and breast cancer resistance protein (BCRP). "
08/01/2009 - "15-Deoxy-delta 12, 14-prostaglandin J2 induces upregulation of multidrug resistance-associated protein 1 via Nrf2 activation in human breast cancer cells."
07/01/2009 - "All tumour samples expressed multidrug resistance-associated protein 1 (MRP1) and breast cancer resistance protein (BCRP). "
|2.||beta-Thalassemia (Cooley's Anemia)
01/01/2013 - "The present study aimed to investigate the role of glutathione efflux transporters, namely cystic fibrosis transmembrane conductance regulator (CFTR) and multidrug resistance-associated protein 1 (MRP1), in the control of glutathione levels and protection against oxidative challenges in beta thalassemia/Hb E erythrocytes. "
05/01/2009 - "The aim of this study was to investigate the expression of multidrug resistance-associated protein 1 (MRP1) and to assess the possible associations with clinicopathological variables and patient outcome in primary ovarian carcinoma. "
05/01/2009 - "Expression of multidrug resistance-associated protein 1 in invasive ovarian carcinoma: implication for prognosis."
02/13/2004 - "In this study we show that P-glycoprotein in multidrug-resistant 2780AD human ovarian carcinoma cells and multidrug resistance-associated protein 1 in multidrug-resistant HT29col human colon carcinoma cells are predominantly located in Lubrol-based detergent-insoluble glycosphingolipid-enriched membrane domains. "
10/01/1999 - "Drug resistance-associated markers P-glycoprotein, multidrug resistance-associated protein 1, multidrug resistance-associated protein 2, and lung resistance protein as prognostic factors in ovarian carcinoma."
02/20/2002 - "The impact of the ABC transporters breast cancer resistance protein/mitoxantrone resistance associated transporter (BCRP/MXR), multidrug resistance-associated protein 1 (MRP1) and multidrug resistance gene-1/P-glycoprotein (MDR1/PGP) on the multidrug resistance (MDR) phenotype in chemoresistance and thermoresistance was investigated in the parental human gastric carcinoma cell line EPG85-257P, the atypical MDR subline EPG85-257RNOV, the classical MDR subline EPG85-257RDB and their thermoresistant counterparts EPG85-257P-TR, EPG85-257RNOV-TR and EPG85-257RDB-TR. "
05/01/2008 - "Overexpression of the multidrug resistance-associated protein 1 (MRP1) gene has been linked with resistance to chemotherapy in vitro, but little is known about its clinical impact on acute leukemia patients. "
01/01/2013 - "B4GALT family mediates the multidrug resistance of human leukemia cells by regulating the hedgehog pathway and the expression of p-glycoprotein and multidrug resistance-associated protein 1."
12/01/2008 - "We studied P-gp and multidrug resistance-associated protein 1 (MRP1) expression and functional activities in 43 newly diagnosed acute leukemia cases (19 paediatric ALL cases and 24 adult AML cases). "
12/01/2012 - "Multidrug resistance (MDR), which is mediated by multiple drug efflux ATP-binding cassette (ABC) transporters, is a critical issue in the treatment of acute leukemia, with permeability glycoprotein (P-gp), multidrug resistance-associated protein 1, and breast cancer resistance protein (i.e., ABCG2) consistently being shown to be key effectors of MDR in cell line studies. "
|2.||Glutathione (Reduced Glutathione)
|3.||Janus Kinase 2
|4.||Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)
|6.||major vault protein
|7.||Adenosine Triphosphate (ATP)
|8.||ATP-Binding Cassette Transporters (ABC Transporters)
|9.||Proteins (Proteins, Gene)
|10.||multidrug resistance-associated protein 2
|1.||Chinese Traditional Medicine (Traditional Chinese Medicine)
|2.||Drug Therapy (Chemotherapy)
|4.||Combination Drug Therapy (Combination Chemotherapy)